Who
Manner Carrie Eglinton
Director
Company insider
Files Form 4 as: Director, Repligen; President & CEO, OraSure Technologies; SVP, Advanced Diagnostics, Quest Diagnostics.
In numbers
- Trades disclosed
- 77
- Buys
- 5
- Sells
- 1
- Bought
- $778K
- Sold
- $555K
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 21 Feb 2017
- Last trade
- 14 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 18 May 2026 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —995 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,239 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,239 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —995 at $0.00 | filing |
| 20 Mar 2026filed 23 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Bought | $95K32,300 at $2.93 | filing |
| 20 Mar 2026filed 23 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Bought | $95K32,300 at $2.93 | filing |
| 13 Mar 2026filed 16 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Bought | $66K22,022 at $3.00 | filing |
| 13 Mar 2026filed 16 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Bought | $66K22,022 at $3.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code A | —355,464 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code A | —355,464 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code A | —129,032 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code F | $171K56,116 at $3.04 | filing |
| 1 Mar 2026filed 3 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code F | $373K122,655 at $3.04 | filing |
| 1 Mar 2026filed 3 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code A | —129,032 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code F | $171K56,116 at $3.04 | filing |
| 1 Mar 2026filed 3 Mar 2026 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code F | $373K122,655 at $3.04 | filing |
| 4 Jun 2025filed 5 Jun 2025 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code A | —335,710 at $0.00 | filing |
| 4 Jun 2025filed 5 Jun 2025 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code F | $423K146,000 at $2.90 | filing |
| 4 Jun 2025filed 5 Jun 2025 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code F | $137K47,249 at $2.90 | filing |
| 15 May 2025filed 19 May 2025 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,800 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.